In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Yue LuState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300350, China.ORCID 0009-0003-4911-5765 Tianlei WenState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300350, China.ORCID 0000-0001-5321-0093 Guimin ZhangState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300350, China.ORCID 0009-0007-7791-3608 Tingting MengState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300350, China.ORCID 0009-0007-9391-6294 Tianjin LiuState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300350, China.
Xinyan WangState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300350, China.ORCID 0009-0005-7692-1003 Yuequan ShenState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300350, China.ORCID 0000-0002-3775-0900 Xue YangState Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300350, China.ORCID 0000-0002-4960-0950 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Metabotropic glutamate (mGlu) receptors are class C G protein-coupled receptor involved in synaptic transmission and neurological disorders. Group I mGlu receptors (mGlu1 and mGlu5) predominantly couple to G
Indexed as
GTP-Binding ProteinsReceptors, Metabotropic GlutamateAllosteric RegulationAnimalsCryoelectron MicroscopyGlutamic AcidGTP-Binding Protein alpha Subunits, Gq-G11HumansModels, MolecularProtein BindingProtein ConformationGlutamic AcidGTP-Binding Protein alpha Subunits, Gq-G11GTP-Binding Proteinsmetabotropic glutamate receptor type 1Receptors, Metabotropic Glutamate
Identifiers
PMID42430471
PMCPMC13353412
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390